shareholder support for the 2

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Aug 19, 2014 at 5:44 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Regulatory filings with the Securities and Exchange Commission show that 76 of Allergan’s top 100 shareholders as of the end of March sold some of their shares in the second quarter. Four of them dumped their entire stakes, while ten sold over 90% of their stake.

    Valeant Pharmaceuticals shareholders seem to be a little more tolerant of the action, as 43 of the top 100 investors sold some of their shares during the second quarter. Two of them sold completely out of the drug maker, while four sold over 90% of their stake.
     

  2. Anonymous

    Anonymous Guest

    I mean the stock spiked from 120 to 170, wouldn't most sane people sell some of their stock?

    VRX shareholders would hold onto their stock because they keep hoping the deal will go through and somehow the stock will skyrocket to 200 (or whatever was being claimed at the time).
     
  3. Anonymous

    Anonymous Guest

    Lots if news out today suggesting progress to a vote?
     
  4. Anonymous

    Anonymous Guest

    It's being reported that Ackman will file paperwork for the special Allergan shareholder meeting today. This should have sent the stocks back up, but AGN is down at the moment. Probably because it's also expected that Allergan will void the the request. The dispute will go to the courts. I'd expect Ackman/Valeant to win, but it's also a matter of how long it will take. A long drawn out fight is equivalent to losing the case.
     
  5. Anonymous

    Anonymous Guest

    Valeant isn't going to be able to hang on for as long as Allergan will be able to draw this out.
     
  6. Anonymous

    Anonymous Guest

    YEA!!!
     
  7. Anonymous

    Anonymous Guest

    Afraid you're wrong . Valeant has time on its side
     
  8. Anonymous

    Anonymous Guest

    No time and definitely no MONEY!!